BUZZ-AstraZeneca: hit as diabetes drug combo denied approval

** AstraZeneca down c.2 pct and top loser on a positive Stoxx 600 healthcare index after U.S. health regulators declines to approve pharma co's fixed-dose combination of the diabetes drugs...